Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate shiga toxin receptor globotetraosylceramide

Infection and Immunity

Volumn 78, Issue 11, 2010, Pages 4488-4499

  Zumbrun, Steven D ^a   Hanson, Leanne ^a   Sinclair, James F ^a   Freedy, James ^a   Melton Celsa, Angela R ^a   Rodriguez Canales, Jaime ^b   Hanson, Jeffrey C ^b   O'Brien, Alison D ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLOBOTETRAOSYLCERAMIDE; GLOBOTRIAOSYLCERAMIDE; MESSENGER RNA; RECEPTOR; SYNTHETASE; UNCLASSIFIED DRUG; VEROTOXIN 1; VEROTOXIN 2;

ADULT; AGED; ARTICLE; BINDING AFFINITY; COLON MUCOSA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; INTESTINE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

CELL LINE; CELLS, CULTURED; COLON; EPITHELIAL CELLS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GALACTOSYLTRANSFERASES; GLOBOSIDES; HUMANS; ORGAN CULTURE TECHNIQUES; RNA, MESSENGER; SHIGA TOXIN 1; SHIGA TOXIN 2; SHIGA-TOXIGENIC ESCHERICHIA COLI;

EID: 78049419516     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00620-10     Document Type: Article

References (61)

1. Acheson, D. W., R. Moore, S. De Breucker, L. Lincicome, M. Jacewicz, E. Skutelsky, and G. T. Keusch. 1996. Translocation of Shiga toxin across polarized intestinal cells in tissue culture. Infect. Immun. 64:3294-3300.
2. Ahn, C. K., N. J. Holt, and P. I. Tarr. 2009. Shiga-toxin producing Escherichia coli and the hemolytic uremic syndrome: what have we learned in the past 25 years? Adv. Exp. Med. Biol. 634:1-17.
3. Bateman, E. 1998. Autoregulation of eukaryotic transcription factors. Prog. Nucleic Acid Res. Mol. Biol. 60:133-168.
4. Beery, J., M. Doyle, and N. Higley. 1984. Cytotoxic activity of Escherichia coli O157:H7 culture filtrate on the mouse colon and kidney. Curr. Microbiol. 11:335-342.
5. Berky, J. J., J. Hunziker, Jr., and L. A. Zolotor. 1981. Laboratory apparatus for cloning mammalian cells. U.S. patent 4247646.
6. Bitzan, M. 2009. Treatment options for HUS secondary to Escherichia coli O157:H7. Kidney Int. Suppl. 2009:S62-S66.
7. Boyd, B., and C. Lingwood. 1989. Verotoxin receptor glycolipid in human renal tissue. Nephron 51:207-210.
8. Boyd, B., G. Magnusson, Z. Zhiuyan, and C. A. Lingwood. 1994. Lipid modulation of glycolipid receptor function. Availability of Gal(alpha 1-4)Gal disaccharide for verotoxin binding in natural and synthetic glycolipids. Eur. J. Biochem. 223:873-878.
9. DeGrandis, S., H. Law, J. Brunton, C. Gyles, and C. A. Lingwood. 1989. Globotetraosylceramide is recognized by the pig edema disease toxin. J. Biol. Chem. 264:12520-12525.
10. Devenish, J., C. Gyles, and J. LaMarre. 1998. Binding of Escherichia coli verotoxins to cell surface protein on wild-type and globotriaosylceramidedeficient Vero cells. Can. J. Microbiol. 44:28-34.
11. Flagler, M. J., S. S. Mahajan, A. A. Kulkarni, S. S. Iyer, and A. A. Weiss. 2010. Comparison of binding platforms yields insights into receptor binding differences between shiga toxins 1 and 2. Biochemistry 49:1649-1657.
12. Forzley, B. R., and W. F. Clark. 2009. TTP/HUS and prognosis: the syndrome and the disease(s). Kidney Int. Suppl. 2009:S59-S61.
13. Gasteiger, E., A. Gattiker, C. Hoogland, I. Ivanyi, R. D. Appel, and A. Bairoch. 2003. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 31:3784-3788. (Pubitemid 37442246)
14. Gentry, M. K., and J. M. Dalrymple. 1980. Quantitative microtiter cytotoxicity assay for Shigella toxin. J. Clin. Microbiol. 12:361-366.
15. Head, S. C., M. A. Karmali, M. E. Roscoe, M. Petric, N. A. Strockbine, and I. K. Wachsmuth. 1988. Serological differences between verocytotoxin 2 and shiga-like toxin II. Lancet ii:751.
16. Holgersson, J., P. A. Jovall, and M. E. Breimer. 1991. Glycosphingolipids of human large intestine: detailed structural characterization with special reference to blood group compounds and bacterial receptor structures. J. Biochem. 110:120-131.
17. Holgersson, J., N. Stromberg, and M. E. Breimer. 1988. Glycolipids of human large intestine: difference in glycolipid expression related to anatomical localization, epithelial/non-epithelial tissue and the ABO, Le and Se phenotypes of the donors. Biochimie 70:1565-1574.
18. Huckenbeck, W. 2006. Forensic pathology reviews, vol. 4. Humana Press, Totowa, NJ.
19. Hughes, A. K., P. K. Stricklett, D. Schmid, and D. E. Kohan. 2000. Cytotoxic effect of Shiga toxin-1 on human glomerular epithelial cells. Kidney Int. 57:2350-2359.
20. Jacewicz, M., H. Clausen, E. Nudelman, A. Donohue-Rolfe, and G. T. Keusch. 1986. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J. Exp. Med. 163:1391-1404.
21. Jacewicz, M. S., D. W. Acheson, D. G. Binion, G. A. West, L. L. Lincicome, C. Fiocchi, and G. T. Keusch. 1999. Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis. Infect. Immun. 67:1439-1444.
22. Jones, D. H., C. A. Lingwood, K. R. Barber, and C. W. Grant. 1997. Globoside as a membrane receptor: a consideration of oligosaccharide communication with the hydrophobic domain. Biochemistry 36:8539-8547.
23. Kannagi, R., K. Watanabe, and S. Hakomori. 1987. Isolation and purification of glycosphingolipids by high-performance liquid chromatography. Methods Enzymol. 138:3-12.
24. Karmali, M. A. 1989. Infection by verocytotoxin-producing Escherichia coli. Clin. Microbiol. Rev. 2:15-38.
25. Kashiwamura, M., K. Kurohane, T. Tanikawa, A. Deguchi, D. Miyamoto, and Y. Imai. 2009. Shiga toxin kills epithelial cells isolated from distal but not proximal part of mouse colon. Biol. Pharm. Bull. 32:1614-1617.
26. Kelly, J., A. Oryshak, M. Wenetsek, J. Grabiec, and S. Handy. 1990. The colonic pathology of Escherichia coli O157:H7 infection. Am. J. Surg. Pathol. 14:87-92.
27. Keusch, G. T., M. Jacewicz, D. W. Acheson, A. Donohue-Rolfe, A. V. Kane, and R. H. McCluer. 1995. Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e. Infect. Immun. 63:1138-1141.
28. Keusch, G. T., M. Jacewicz, M. Mobassaleh, and A. Donohue-Rolfe. 1991. Shiga toxin: intestinal cell receptors and pathophysiology of enterotoxic effects. Rev. Infect. Dis. 13(Suppl. 4):S304-S310.
29. Kovbasnjuk, O. 2005. New insights into the role of Shiga toxins in intestinal disease. Gastroenterology 129:1354-1355.
30. Lai, W. S., D. M. Carrick, and P. J. Blackshear. 2005. Influence of nonameric AU-rich tristetraprolin-binding sites on mRNA deadenylation and turnover. J. Biol. Chem. 280:34365-34377.
31. Lindberg, A. A., J. E. Brown, N. Stromberg, M. Westling-Ryd, J. E. Schultz, and K. A. Karlsson. 1987. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J. Biol. Chem. 262:1779-1785.
32. Lingwood, C. A. 1996. Role of verotoxin receptors in pathogenesis. Trends Microbiol. 4:147-153.
33. Lingwood, C. A. 2003. Shiga toxin receptor glycolipid binding. Pathology and utility. Methods Mol. Med. 73:165-186.
34. Lingwood, C. A. 1994. Verotoxin-binding in human renal sections. Nephron 66:21-28.
35. Lingwood, C. A., H. Law, S. Richardson, M. Petric, J. L. Brunton, S. De Grandis, and M. Karmali. 1987. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J. Biol. Chem. 262:8834-8839.
36. Miyamoto, Y., M. Iimura, J. B. Kaper, A. G. Torres, and M. F. Kagnoff. 2006. Role of Shiga toxin versus H7 flagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo. Cell Microbiol. 8:869-879.
37. Mobassaleh, M., O. Koul, K. Mishra, R. H. McCluer, and G. T. Keusch. 1994. Developmentally regulated Gb3 galactosyltransferase and alpha-galactosidase determine Shiga toxin receptors in intestine. Am. J. Physiol. 267:G618-G624.
38. Muthing, J., C. H. Schweppe, H. Karch, and A. W. Friedrich. 2009. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thromb. Haemost. 101:252-264.
39. O'Brien, A. D., and A. R. Melton-Celsa. 2000. Handbook of experimental pharmacology, vol. 145. Springer-Verlag, Berlin, Germany.
40. Obrig, T. G., C. B. Louise, C. A. Lingwood, B. Boyd, L. Barley-Maloney, and T. O. Daniel. 1993. Endothelial heterogeneity in Shiga toxin receptors and responses. J. Biol. Chem. 268:15484-15488.
41. O'Loughlin, E. V., and R. M. Robins-Browne. 2001. Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells. Microbes Infect. 3:493-507.
42. Ohmi, K., N. Kiyokawa, T. Takeda, and J. Fujimoto. 1998. Human microvascular endothelial cells are strongly sensitive to Shiga toxins. Biochem. Biophys. Res. Commun. 251:137-141.
43. Okuda, T., N. Tokuda, S. Numata, M. Ito, M. Ohta, K. Kawamura, J. Wiels, T. Urano, O. Tajima, and K. Furukawa. 2006. Targeted disruption of Gb3/ CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins. J. Biol. Chem. 281: 10230-10235.
44. Pai, C. H., J. K. Kelly, and G. L. Meyers. 1986. Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infect. Immun. 51: 16-23.
45. Perera, L. P., L. R. Marques, and A. D. O'Brien. 1988. Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay. J. Clin. Microbiol. 26:2127-2131.
46. Ren, J., I. Utsunomiya, K. Taguchi, T. Ariga, T. Tai, Y. Ihara, and T. Miyatake. 1999. Localization of verotoxin receptors in nervous system. Brain Res. 825:183-188. (Pubitemid 29222875)
47. Richardson, S. E., T. A. Rotman, V. Jay, C. R. Smith, L. E. Becker, M. Petric, N. F. Olivieri, and M. A. Karmali. 1992. Experimental verocytotoxemia in rabbits. Infect. Immun. 60:4154-4167.
48. Schuller, S., G. Frankel, and A. D. Phillips. 2004. Interaction of Shiga toxin from Escherichia coli with human intestinal epithelial cell lines and explants: Stx2 induces epithelial damage in organ culture. Cell Microbiol. 6:289-301.
49. Schuller, S., R. Heuschkel, F. Torrente, J. B. Kaper, and A. D. Phillips. 2007. Shiga toxin binding in normal and inflamed human intestinal mucosa. Microbes Infect. 9:35-39.
50. Shimizu, T., T. Sato, S. Kawakami, T. Ohta, M. Noda, and T. Hamabata. 2007. Receptor affinity, stability and binding mode of Shiga toxins are determinants of toxicity. Microb. Pathog. 43:88-95.
51. Shin, I. S., S. Ishii, J. S. Shin, K. I. Sung, B. S. Park, H. Y. Jang, and B. W. Kim. 2009. Globotriaosylceramide (Gb3) content in HeLa cells is correlated to Shiga toxin-induced cytotoxicity and Gb3 synthase expression. BMB Rep. 42:310-314.
52. Siddiqui, B., J. S. Whitehead, and Y. S. Kim. 1978. Glycosphingolipids in human colonic adenocarcinoma. J. Biol. Chem. 253:2168-2175.
53. Smith, M. J., H. M. Carvalho, A. R. Melton-Celsa, and A. D. O'Brien. 2006. The 13C4 monoclonal antibody that neutralizes Shiga toxin Type 1 (Stx1) recognizes three regions on the Stx1 B subunit and prevents Stx1 from binding to its eukaryotic receptor globotriaosylceramide. Infect. Immun. 74:6992-6998.
54. Tam, P., R. Mahfoud, A. Nutikka, A. A. Khine, B. Binnington, P. Paroutis, and C. Lingwood. 2008. Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies. J. Cell. Physiol. 216:750-763.
55. te Loo, D. M., L. A. Monnens, T. J. van Der Velden, M. A. Vermeer, F. Preyers, P. N. Demacker, L. P. van Den Heuvel, and V. W. van Hinsbergh. 2000. Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood 95:3396-3402.
56. Tesh, V. L., J. A. Burris, J. W. Owens, V. M. Gordon, E. A. Wadolkowski, A. D. O'Brien, and J. E. Samuel. 1993. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect. Immun. 61:3392-3402.
57. van Echten, G., and K. Sandhoff. 1993. Ganglioside metabolism. Enzymology, topology, and regulation. J. Biol. Chem. 268:5341-5344.
58. Waddell, T., A. Cohen, and C. A. Lingwood. 1990. Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide. Proc. Natl. Acad. Sci. U. S. A. 87:7898-7901.
59. Waddell, T., S. Head, M. Petric, A. Cohen, and C. Lingwood. 1988. Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem. Biophys. Res. Commun. 152:674-679.
60. Wen, S. X., L. D. Teel, N. A. Judge, and A. D. O'Brien. 2006. A plant-based oral vaccine to protect against systemic intoxication by Shiga toxin type 2. Proc. Natl. Acad. Sci. U. S. A. 103:7082-7087.
61. Whyte, D. A., and R. N. Fine. 2008. Acute renal failure in children. Pediatr. Rev. 29:297, 299-306.